Minimed Group, Inc. (MMED)

Minimed Group Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Oct 24, 2025	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Net Income	-211	-213	-112	-96
Depreciation & Amortization	153	143	129	115
Stock-Based Compensation	45	41	38	35
Provision & Write-off of Bad Debts	20	21	22	15
Other Operating Activities	37	26	38	15
Change in Accounts Receivable	-70	-66	-105	-70
Change in Inventory	-54	-19	5	-28
Change in Accounts Payable	70	191	-4	14
Change in Other Net Operating Assets	24	16	30	-6
Operating Cash Flow	14	140	41	-6
Operating Cash Flow Growth	-	241.46%	-	-
Capital Expenditures	-221	-193	-148	-167
Investment in Securities	-	-	6	-13
Other Investing Activities	-10	-	-15	-
Investing Cash Flow	-231	-193	-157	-180
Other Financing Activities	215	10	112	185
Financing Cash Flow	215	10	112	185
Net Cash Flow	-1	-43	-4	-1
Free Cash Flow	-207	-53	-107	-173
Free Cash Flow Margin	-7.17%	-1.95%	-4.33%	-7.71%
Levered Free Cash Flow	-	106.5	-79.88	-
Unlevered Free Cash Flow	-	106.5	-79.88	-
Change in Working Capital	-30	122	-74	-90

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q